CVS Health Corporation (CVS) Stock Analysis 2026
BriMind AI Score
ProprietaryScore based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.
AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →
About CVS Health Corporation
CVS Health is a diversified healthcare company operating across three major segments: Health Care Benefits (Aetna insurance), Health Services (pharmacy benefit management through CVS Caremark, Signify Health), and Pharmacy & Consumer Wellness (retail pharmacies, MinuteClinics, and PBM services). CVS has been attempting to evolve from a pharmacy retailer into an integrated healthcare company, but its Aetna acquisition and subsequent investments in home health and primary care have created execution complexity.
How CVS Health Makes Money
CVS earns through insurance premiums (Aetna Medicare Advantage, commercial health insurance), PBM fee-for-service (managing drug benefits for employers and health plans), retail pharmacy dispensing fees, and front-store retail. The company has invested in primary care (Oak Street Health, acquired 2023) and home health (Signify) to create an integrated care model. High integration between Aetna insurance, Caremark PBM, and CVS pharmacies theoretically reduces costs and improves member health outcomes.
CVS Health Revenue & Profitability Breakdown
This chart shows how CVS Health's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.
Key Financial Metrics
CVS Health Corporation trades at a trailing P/E of 24.55x, generates $8.08B in free cash flow, runs a debt/equity ratio of 95.50, and converts shareholder equity into profit at a 6.2% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.
Wall Street Analyst Consensus
Wall Street analysts covering CVS Health Corporation currently haven't converged on a clear consensus rating, with a mean 12-month price target of $116.08 (+30.7% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.
Technical Price Signals
CVS is currently in a short-term downtrend, trading below its 50-day average of $101.21 and above its 200-day average of $86.19. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.
CVS Investment Case: Bull vs Bear
CVS's investment case breaks down into 4 bull points and 4 bear points below. The bull case outlines the key reasons the stock could outperform — competitive advantages, growth catalysts, and market tailwinds. The bear case highlights the most significant risks. A strong bull case with manageable bear risks typically makes for a more compelling investment.
Bull Case (Reasons to Buy)
- Integrated healthcare model — combining insurance, PBM, primary care, and pharmacy — theoretically allows CVS to reduce total cost of care and improve outcomes better than fragmented competitors.
- Medicare Advantage growth: Aetna's MA membership is growing as Baby Boomers age into Medicare, a structural multi-decade demographic tailwind.
- Oak Street Health primary care model (value-based primary care for seniors) has demonstrated clinical and financial results in its existing markets.
- CVS's 10,000+ pharmacy locations are a distribution asset for vaccines, testing, and preventive care that retail competitors cannot replicate.
Bear Case (Key Risks)
- Aetna Medicare Advantage has been severely impacted by higher-than-expected medical costs — utilization surged in 2023-2024, causing Aetna to report large operating losses in MA.
- CVS's complex multi-segment structure has created execution challenges — integrating Oak Street, Signify, and Aetna while managing the core PBM and retail businesses has been difficult.
- PBM regulatory scrutiny is increasing — FTC investigations into PBM practices, transparency requirements, and potential fee structure changes could impair Caremark profitability.
- Retail pharmacy headwinds are structural — pharmacy reimbursement rates from PBMs have been declining, and front-store traffic is declining as consumers shift to Amazon and dollar stores.
What to Watch: CVS Key Metrics
CVS Stock — Frequently Asked Questions
Compare CVS with Peers
Unlock the Full CVS Analysis
Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.